Research Project
Project Title: |
A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis (MISSION) |
Project Type: |
Clinical Trial, Enrolment ongoing |
Disease group(s): |
Immune glomerulopathies |
Project Summary: |
The MISSION study (NCT03393013) is a Phase 1b/2, open-label study to evaluate safety, tolerability, and preliminary efficacy of zetomipzomib in patients with SLE with ± LN. |
Lead principal investigator(s): |
Smaragdi Marinaki, Athens |
Co-investigator(s): |
Ioannis Boletis, Athens Chrysanthi Skalioti, Athens |
Project Period: |
01/2024 - 01/2025 |
ClinicalTrials.gov: |
NCT03393013 |
« Back to research page